Eastman, K.
Gerlach, M.
Piec, I.
Greeves, J.
Fraser, W.
Funding for this research was provided by:
Ministry of Defence
Article History
Received: 20 April 2020
Accepted: 12 January 2021
First Online: 9 February 2021
Compliance with ethical standards
:
: Professor William Fraser has received unrestricted research grants, sat on advisory boards and given lectures on behalf of Eli Lilly, NPS and Nycomed. Dr Matt Gerlach, Dr Isabelle Piec, Prof Julie Greeves and Mrs Katharine Eastman have no conflicts of interest.
: This study was not a human or animal experiment so no ethical approval was required.
: This study used data already in the public domain, there was no requirement for consent to be taken.
: This study used data already in the public domain, there was no requirement for consent to be taken.
: Software used was <i>Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.</i>RoB 2 tool [Computer program]. Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng H-Y, Corbett MS, Eldridge SM, Hernán MA, Hopewell S, Hróbjartsson A, Junqueira DR, Jüni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT. RoB 2: a revised tool for assessing risk of bias in randomised trials. <i>BMJ</i> 2019; <b>366</b>: l4898.